We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
CEGX Introduces TMWG Integrated Workflow System
Product News

CEGX Introduces TMWG Integrated Workflow System

CEGX Introduces TMWG Integrated Workflow System
Product News

CEGX Introduces TMWG Integrated Workflow System


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "CEGX Introduces TMWG Integrated Workflow System"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cambridge Epigenetix (CEGX) has announced the launch of its TrueMethyl® Whole Genome (TMWG) integrated workflow system for processing DNA samples. The new system includes all-in-one reagents for sample conversion, library creation and indexing, combined with bioinformatic tools to enable accurate DNA modification analysis, designed to reduce experimental costs and improve the ease and accessibility of bisulfite sequencing for researchers.

The workflow has been specifically designed to allow the technology to be accessible to researchers studying DNA modifications through next generation sequencing methods. The TMWG kit incorporates CEGX’s TrueMethyl oxidative bisulfite (oxBS) technology, which allows researchers to accurately quantify different DNA modifications at single-base resolution, and proprietary library preparation methods, which have been designed to overcome the limitations of traditional bisulfite library construction to improve the yield and quality of epigenetic data. The bioinformatic tools comprise a series of scripts for QC analysis and biological analysis of the resultant sequencing data.

Dr Geoff Smith, CEO at Cambridge Epigenetix, commented: “The launch of TMWG opens up new opportunities in epigenetics research by allowing customers the ability to access the power of whole genome epigenetic information in an integrated, cost-effective solution that combines sample preparation and DNA sequence analysis.  Working in collaboration with leading research groups, we have demonstrated that TMWG provides unprecedented levels of data accuracy of DNA modifications at base-pair resolution and at genome-wide level, and we look forward to supporting our customers in unlocking the tremendous potential of epigenetics.”

Advertisement